Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Liver Metastases From Solid Tumors: A Prospective Cohort Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07875465

Title field or adapter rule

{'original_value': 'Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Liver Metastases From Solid Tumors: A Prospective Cohort Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:23.286357+00:00

Published At

2026-10-15T00:00:00+00:00

Record Updated At

2026-10-15

Source Retrieved At

2026-10-31T22:17:52.415050+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Liver Metastases", "Non-Small Cell Lung Cancer", "Colorectal Cancer (Diagnosis)", "Pancreatic Cancer Metastatic", "Solid Tumors"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-15", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07875465"

protocolSection.identificationModule.officialTitle

"Intestinal Low-Dose Radiotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Liver Metastases From Solid Tumors: A Prospective Cohort Study"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Liver Metastases (protocolSection.conditionsModule.conditions)
• Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Colorectal Cancer (Diagnosis) (protocolSection.conditionsModule.conditions)
• Pancreatic Cancer Metastatic (protocolSection.conditionsModule.conditions)
• Solid Tumors (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['ILDR Combined With ICIs and Chemotherapy'], 'description': 'Single fraction of 1 Gy delivered to the intestine (jejunum, ileum, and mesentery) using IMRT/VMAT.', 'name': 'Intestinal Low-Dose Radiotherapy (ILDR)', 'type': 'RADIATION'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['ILDR Combined With ICIs and Chemotherapy'], 'description': 'Administered 24-72 hours after ILDR, every 3 weeks, for up to 2 years.', 'name': 'PD-1/PD-L1 inhibitors', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['ILDR Combined With ICIs and Chemotherapy'], 'description': 'Regimens based on tumor type: docetaxel (Cohort A), platinum-based doublet (Cohort B), or XELOX/FOLFOX/FOLFIRI/AG (Cohort C).', 'name': 'Combined Chemotherapy', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• PD-1/PD-L1 inhibitors (protocolSection.armsInterventionsModule.interventions[].name)
• Combined Chemotherapy (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.